G9912 Hepatitis b virus (hbv) status assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy
Short descriptor: Hbv status assesed and int
Look up G9912 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.
G9912 is the HCPCS Level II code for Hepatitis b virus (hbv) status assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy (2026). It belongs to Section G — Procedures / Professional Services (Temporary). Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Not separately priced by Part B.
Classification & CMS Attributes
- Medicare Coverage
- Carrier judgment (code C)
- Part B Pricing
- Not separately priced by Part B (indicator 00)
- Type of Service
- Medical care
- Effective Date
- 2018-01-01
- 2026 Maintenance
- No change this year
References
Cite This Page
Reference G9912 with the canonical source and edition:
G9912 — Hepatitis b virus (hbv) status assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/G9912
Canonical URL: https://icd10codingpro.com/hcpcs-codes/G9912